APA
McClung M. R., O'Donoghue M. L., Papapoulos S. E., Bone H., Langdahl B., Saag K. G., Reid I. R., Kiel D. P., Cavallari I., Bonaca M. P., Wiviott S. D., de Villiers T., Ling X., Lippuner K., Nakamura T., Reginster J., Rodriguez-Portales J. A., Roux C., Zanchetta J., Zerbini C. A. F., Park J., Im K., Cange A., Grip L. T., Heyden N., DaSilva C., Cohn D., Massaad R., Scott B. B., Verbruggen N., Gurner D., Miller D. L., Blair M. L., Polis A. B., Stoch S. A., Santora A., Lombardi A., Leung A. T., Kaufman K. D. & Sabatine M. S. (20200521). Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. : The lancet. Diabetes & endocrinology.
Chicago
McClung Michael R, O'Donoghue Michelle L, Papapoulos Socrates E, Bone Henry, Langdahl Bente, Saag Kenneth G, Reid Ian R, Kiel Douglas P, Cavallari Ilaria, Bonaca Marc P, Wiviott Stephen D, de Villiers Tobias, Ling Xu, Lippuner Kurt, Nakamura Toshitaka, Reginster Jean-Yves, Rodriguez-Portales Jose Adolfo, Roux Christian, Zanchetta José, Zerbini Cristiano A F, Park Jeong-Gun, Im KyungAh, Cange Abby, Grip Laura T, Heyden Norman, DaSilva Carolyn, Cohn Dosinda, Massaad Rachid, Scott Boyd B, Verbruggen Nadia, Gurner Deborah, Miller Deborah L, Blair Micki L, Polis Adam B, Stoch S Aubrey, Santora Arthur, Lombardi Antonio, Leung Albert T, Kaufman Keith D and Sabatine Marc S. 20200521. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. : The lancet. Diabetes & endocrinology.
Harvard
McClung M. R., O'Donoghue M. L., Papapoulos S. E., Bone H., Langdahl B., Saag K. G., Reid I. R., Kiel D. P., Cavallari I., Bonaca M. P., Wiviott S. D., de Villiers T., Ling X., Lippuner K., Nakamura T., Reginster J., Rodriguez-Portales J. A., Roux C., Zanchetta J., Zerbini C. A. F., Park J., Im K., Cange A., Grip L. T., Heyden N., DaSilva C., Cohn D., Massaad R., Scott B. B., Verbruggen N., Gurner D., Miller D. L., Blair M. L., Polis A. B., Stoch S. A., Santora A., Lombardi A., Leung A. T., Kaufman K. D. and Sabatine M. S. (20200521). Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. : The lancet. Diabetes & endocrinology.
MLA
McClung Michael R, O'Donoghue Michelle L, Papapoulos Socrates E, Bone Henry, Langdahl Bente, Saag Kenneth G, Reid Ian R, Kiel Douglas P, Cavallari Ilaria, Bonaca Marc P, Wiviott Stephen D, de Villiers Tobias, Ling Xu, Lippuner Kurt, Nakamura Toshitaka, Reginster Jean-Yves, Rodriguez-Portales Jose Adolfo, Roux Christian, Zanchetta José, Zerbini Cristiano A F, Park Jeong-Gun, Im KyungAh, Cange Abby, Grip Laura T, Heyden Norman, DaSilva Carolyn, Cohn Dosinda, Massaad Rachid, Scott Boyd B, Verbruggen Nadia, Gurner Deborah, Miller Deborah L, Blair Micki L, Polis Adam B, Stoch S Aubrey, Santora Arthur, Lombardi Antonio, Leung Albert T, Kaufman Keith D and Sabatine Marc S. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. : The lancet. Diabetes & endocrinology. 20200521.